Sunday, March 29, 2026

Hyundai, Kia Face a $3.75B Hit if U.S. Tariffs Return to 25%: What Should Seoul Do Next?

U.S. tariffs on Korean cars may rise to 25%, threatening Hyundai and Kia's profits with potential losses exceeding $3.75 billion.

2026: South Koreans Favor Japan’s PM Takaichi Over Other Leaders – What’s Behind the Shift?

South Koreans show higher approval for Japan's Prime Minister Takaichi at 22%, contrasting with low ratings for other leaders.

LS ELECTRIC wins tax incentive approval for Utah production base, accelerating expansion

LS ELECTRIC secures tax incentives for a $168M expansion in Utah, aiming to enhance its North American operations and production capacity.

Tag: Congenital Hyperinsulinism

North KoreaKoreaKimMilitarySouth KoreaAIrelationsmarketInternational

FDA Grants Breakthrough Therapy Designation to Hanmi’s Epheglucagon: What This Means for Rare Disease Treatment

Hanmi Pharmaceutical's efpegerglucagon receives FDA Breakthrough Therapy designation for treating rare Congenital Hyperinsulinism, with Phase 2 results due soon.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.